跳至主要内容
临床试验/NCT00545298
NCT00545298终止2 期

An Investigation of the Topical Application of Gaseous Nitric Oxide on Safety and Efficacy in Venous Stasis Leg Ulcers of the Lower Extremities

Nitric BioTherapeutics, Inc1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
发起方
入组人数
4
试验地点
1
主要终点
Wound Healing

研究概览

简要总结

This study will test the safety and efficacy of nitric oxide gas in the treatment of venous leg ulcers

详细描述

Prospective, single center. Controlled study of a moisture retentive wound dressing and sustained compression with 6 weeks of 8 hour daily nitric oxide treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must have a venous stasis ulcer between the knee and the ankle.
  • Ulcer duration must be 60 days or greater

排除标准

  • Has an ulcer that is deemed by the Investigator to be caused primarily by a medical condition other than venous insufficiency
  • Suffers from diabetes mellitus with HbA1c ≥ 8%
  • Suffers from clinically significant arterial disease
  • Is pregnant, a nursing mother or a woman of child bearing potential who is not using an adequate form of contraception (or abstinent)
  • The above is a partial list of the inclusion and exclusion criteria; however, other inclusion and exclusion criteria may apply.

研究组 & 干预措施

B Same treatment for 6 weeks

Experimental

200ppm NO gas 8hrs/day 6 weeks NO gas in nitrogen is delivered constantly to a patch over the wound

干预措施: Nitric Oxide - same dose 6 wks (Drug)

C - modified treatment, 5 wks lower dose

Experimental

200 ppm No gas 8 hrs/day 1 wk, 20ppm 8hrs/day 5 weeks Gas is NO in nitrogen delivered constantly for 8 hours to a patch over the wound

干预措施: Nitric Oxide modified treatment (Drug)

结局指标

主要结局

Wound Healing

时间窗: Week 20

% Re-epithelialization

Adverse Events (AEs) and Serious Adverse Events (SAEs)

时间窗: up to 24 weeks

All reported adverse events, related or unrelated to the study drug.

次要结局

未报告次要终点

研究者

发起方
Nitric BioTherapeutics, Inc
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验